Results 251 to 260 of about 33,788 (287)
Some of the next articles are maybe not open access.

Rimegepant. Calcitonin gene-related peptide (CGRP) receptor antagonist, Treatment of migraine

Drugs of the Future, 2019
Rimegepant is an oral calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under development by Biohaven Pharmaceuticals for the acute and preventive treatment of migraine. Among patients with acute migraine, significant clinical efficacy has been reported with a rimegepant single dose.
Lionetto, L.   +5 more
openaire   +1 more source

Calcitonin gene-related peptides and their receptors

1999
Calcitonin gene-related peptide (CGRP) is an abundant 37 amino acid neuropeptide which was discovered in 1982 [1]. It is an extremely potent vasodilator, causing noticeable effects on the human forearm when given in femtomole quantities [2]. The peptide is found as two variants, α-and β-CGRP, but these differ only by three amino acids in man, and the ...
openaire   +1 more source

Receptors for calcitonin gene related peptide (CGRP) in gastrointestinal epithelia

Canadian Journal of Physiology and Pharmacology, 1995
A pharmacological comparison of calcitonin gene related peptide (CGRP) receptors expressed in normal rat colon mucosa and two human adenocarcinoma cell lines has been undertaken. Using voltage-clamp techniques electrogenic ion transport was continuously monitored across either mucosal preparations or confluent epithelial monolayers grown on permeable ...
openaire   +2 more sources

Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions

European Journal of Endocrinology, 1995
Muff R, Born W, Fischer JA. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 1995;133:17–20. ISSN 0804–4643 Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin are structurally related peptides with N-terminal 6–
R, Muff, W, Born, J A, Fischer
openaire   +2 more sources

Pharmacology of receptors for calcitonin gene-related peptide and amylin

Trends in Pharmacological Sciences, 1995
Calcitonin gene-related peptide (CGRP), a widespread neuropeptide with multiple actions, has substantial homology with amylin, a peptide implicated in insulin-resistant diabetes, and adrenomedullin, a recently discovered potent vasodilator. There is controversy over the existence of CGRP receptor subtypes, and whether independent receptors exist for ...
openaire   +2 more sources

hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery.

The Journal of Pharmacology and Experimental Therapeutics, 1990
The C-terminal fragment of human calcitonin gene-related peptide (CGRP), hCGRP8-37, fails to induce any biological activity in a variety of isolated tissues and behavioral assays even though it possesses nanomolar affinity for [125I]hCGRP alpha binding sites in the central nervous system and peripheral membrane preparations. However, hCGRP8-37 displays
T, Dennis   +6 more
openaire   +2 more sources

Interaction of Calcitonin and Calcitonin Gene-Related Peptide at Receptor Sites in Target Tissues

Science, 1985
Discrete receptor sites for calcitonin (CT) and calcitonin gene-related peptide (CGRP) were found in the nervous system and in peripheral tissues. Each peptide was capable of cross-reacting with the specific receptor of the other. In contrast to CT receptors, CGRP receptors were not linked to adenylate cyclase.
D, Goltzman, J, Mitchell
openaire   +2 more sources

Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity

Trends in Endocrinology & Metabolism, 2002
Calcitonin gene-related peptide (CGRP) is the most potent vasodilator, and there is a growing body of evidence that this peptide might have multiple other functions. During pregnancy, circulating CGRP levels in rats increase up to the time of delivery, followed by a sharp decline at term and postpartum.
Chandrasekhar, Yallampalli   +4 more
openaire   +2 more sources

Calcitonin gene-related peptide receptor antagonists and triptans

Neurology, 2010
For both patients and clinicians, triptans—serotonin 5-HT 1B/1D receptor agonists—were to migraine, nearly, what dopamine was to Parkinson disease.1 They provided specific therapy, offering a very substantial clinical improvement, and seemed to offer, in equal measure, insights into the pathophysiology of the disorder.2 However, migraine is complex and
openaire   +2 more sources

Receptors for calcitonin gene-related peptide

Neuroscience Research Supplements, 1986
Hideyuki Kobayashi   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy